Perinatal Mood and Anxiety Disorders, Serious Mental Illness, and Delivery-Related Health Outcomes, United States, 2006-2015
Background: National estimates of perinatal mood and anxiety disorders (PMAD) and serious mental illness (SMI) among delivering women over time, as well as associated outcomes and costs, are lacking. The prevalence of perinatal mood and anxiety disorders and serious mental illness from 2006-2015 were estimated as well as associated risk of adverse obstetric outcomes, including severe maternal morbidity and mortality (SMMM), and delivery costs.
Methods: The study was a serial, cross-sectional analysis of National Inpatient Sample data. The prevalence of PMAD and SMI was estimated among delivering women as well as obstetric outcomes, healthcare utilization, and delivery costs using adjusted weighted logistic with predictive margins and generalized linear regression models, respectively.
Results: The study included an estimated 39,025,974 delivery hospitalizations from 2006-2015 in the U.S. PMAD increased from 18.4 (95% CI 16.4-20.0) to 40.4 (95% CI 39.3-41.6) per 1,000 deliveries. SMI also increased among delivering women over time, from 4.2 (95% CI 3.9-4.6) to 8.1 (95% CI 7.9-8.4) per 1,000 deliveries. Medicaid covered 72% (95% CI 71.2-72.9) of deliveries complicated by SMI compared to 44% (95% CI 43.1-45.0) and 43.5% (95% CI 42.5-44.5) among PMAD and all other deliveries, respectively. Women with PMAD and SMI experienced higher incidence of SMMM, and increased hospital transfers, lengths of stay, and delivery-related costs compared to other deliveries (P<.001 for all).
Conclusion: Over the past decade, the prevalence of both PMAD and SMI among delivering women increased substantially across the United States, and affected women had more adverse obstetric outcomes and delivery-related costs compared to other deliveries.
Figure 1
Posted 13 Jun, 2020
On 23 Jul, 2020
On 11 Jun, 2020
On 11 Jun, 2020
On 29 May, 2020
On 19 May, 2020
On 18 May, 2020
On 18 May, 2020
Received 01 Apr, 2020
On 01 Apr, 2020
Invitations sent on 31 Mar, 2020
On 31 Mar, 2020
On 02 Mar, 2020
On 01 Mar, 2020
On 01 Mar, 2020
On 10 Feb, 2020
Received 04 Feb, 2020
Received 04 Feb, 2020
On 25 Jan, 2020
On 01 Dec, 2019
On 20 Nov, 2019
On 04 Nov, 2019
Invitations sent on 04 Nov, 2019
On 04 Nov, 2019
On 03 Nov, 2019
On 29 Oct, 2019
Perinatal Mood and Anxiety Disorders, Serious Mental Illness, and Delivery-Related Health Outcomes, United States, 2006-2015
Posted 13 Jun, 2020
On 23 Jul, 2020
On 11 Jun, 2020
On 11 Jun, 2020
On 29 May, 2020
On 19 May, 2020
On 18 May, 2020
On 18 May, 2020
Received 01 Apr, 2020
On 01 Apr, 2020
Invitations sent on 31 Mar, 2020
On 31 Mar, 2020
On 02 Mar, 2020
On 01 Mar, 2020
On 01 Mar, 2020
On 10 Feb, 2020
Received 04 Feb, 2020
Received 04 Feb, 2020
On 25 Jan, 2020
On 01 Dec, 2019
On 20 Nov, 2019
On 04 Nov, 2019
Invitations sent on 04 Nov, 2019
On 04 Nov, 2019
On 03 Nov, 2019
On 29 Oct, 2019
Background: National estimates of perinatal mood and anxiety disorders (PMAD) and serious mental illness (SMI) among delivering women over time, as well as associated outcomes and costs, are lacking. The prevalence of perinatal mood and anxiety disorders and serious mental illness from 2006-2015 were estimated as well as associated risk of adverse obstetric outcomes, including severe maternal morbidity and mortality (SMMM), and delivery costs.
Methods: The study was a serial, cross-sectional analysis of National Inpatient Sample data. The prevalence of PMAD and SMI was estimated among delivering women as well as obstetric outcomes, healthcare utilization, and delivery costs using adjusted weighted logistic with predictive margins and generalized linear regression models, respectively.
Results: The study included an estimated 39,025,974 delivery hospitalizations from 2006-2015 in the U.S. PMAD increased from 18.4 (95% CI 16.4-20.0) to 40.4 (95% CI 39.3-41.6) per 1,000 deliveries. SMI also increased among delivering women over time, from 4.2 (95% CI 3.9-4.6) to 8.1 (95% CI 7.9-8.4) per 1,000 deliveries. Medicaid covered 72% (95% CI 71.2-72.9) of deliveries complicated by SMI compared to 44% (95% CI 43.1-45.0) and 43.5% (95% CI 42.5-44.5) among PMAD and all other deliveries, respectively. Women with PMAD and SMI experienced higher incidence of SMMM, and increased hospital transfers, lengths of stay, and delivery-related costs compared to other deliveries (P<.001 for all).
Conclusion: Over the past decade, the prevalence of both PMAD and SMI among delivering women increased substantially across the United States, and affected women had more adverse obstetric outcomes and delivery-related costs compared to other deliveries.
Figure 1